although
plant
virus
make
target
cell
open
wound
virus
bind
receptor
molecul
cell
surfac
cross
cell
current
opinion
structur
biolog
wwwsciencedirectcom
viral
enzym
mester
tan
hilgenfeld
wwwsciencedirectcom
current
opinion
structur
biolog
heldwein
ee
lou
h
bender
fc
cohen
gh
eisenberg
rj
harrison
sc
crystal
structur
glycoprotein
b
herp
simplex
viru
scienc
russel
rj
hair
lf
steven
dj
collin
pj
lin
yp
blackburn
gm
hay
aj
gamblin
sj
skehel
jj
structur
avian
influenza
neuraminidas
suggest
new
opportun
drug
design
natur
first
xray
structur
avian
influenza
typei
neuraminidas
reveal
extra
caviti
adjac
activ
site
observ
structur
typeii
variant
latter
use
structurebas
design
oseltamivir
zanamivir
clearli
caviti
exploit
structurebas
design
new
neuraminidas
typei
specif
inhibitor
meylan
e
tschopp
j
tolllik
receptor
rna
helicas
two
parallel
way
trigger
antivir
respons
mol
cell
meylan
e
curran
j
hofmann
k
moradpour
binder
bartenschlag
r
tschopp
j
cardif
adaptor
protein
rigi
antivir
pathway
target
hepat
c
viru
natur
author
describ
new
cardcontain
adaptor
protein
cardif
interact
rigi
helicas
sens
doublestrand
viral
rna
cardif
recruit
sever
kinas
therebi
stimul
nfkb
promot
activ
interestingli
order
perturb
host
immun
respons
eg
interferonb
product
cardif
target
inactiv
serin
proteas
hcv
li
chen
x
garbutt
kc
zhou
p
zheng
n
structur
complex
paramyxoviru
v
protein
viral
hijack
propel
cluster
ubiquitin
ligas
jeroen
r
mester
jinzhi
tan
rolf
hilgenfeld
viral
genom
show
unequal
divers
rang
singlestrand
dna
doublestrand
rna
moreov
virus
quickli
adapt
host
immun
respons
drug
treatment
although
tend
make
optim
use
host
cell
reservoir
protein
virus
need
carri
enzymat
function
may
avail
access
infect
cell
recent
progress
made
structur
understand
viral
enzym
involv
stage
viral
life
cycl
includ
entri
hijack
replic
exit
stage
prime
characterist
virus
absolut
depend
host
reproduct
oblig
parasit
plagu
live
organ
back
dutch
scientist
beyerinck
german
research
loeffler
frosch
establish
base
filtrat
experi
caus
agent
certain
plant
anim
diseas
clearli
smaller
known
bacteria
two
year
later
yellow
fever
first
human
viral
diseas
recogn
major
reed
assist
us
armi
havana
date
viru
speci
belong
genera
famili
identifi
probabl
virus
old
life
earth
broad
public
awar
emerg
view
current
aid
pandem
recent
outbreak
sever
acut
respiratori
syndrom
sar
bird
flu
compar
cell
virus
inde
small
appar
minim
genom
mostli
encod
protein
provid
host
cell
virus
tri
make
optim
use
host
access
reservoir
enzym
also
quickli
effici
adapt
chang
host
immun
respons
drug
treatment
final
genom
flexibl
mani
virus
particular
rna
virus
abl
chang
host
rang
cross
speci
barrier
contrast
live
organ
viral
genom
show
breathtak
divers
singlestrand
ss
dna
doublestrand
ds
rna
size
kb
eg
phycodnavirida
intrigu
except
acanthamoeba
polyphaga
mimiviru
apmv
featur
genom
size
mb
genet
inform
often
program
highli
effici
way
display
featur
overlap
gene
make
full
use
possibl
encod
homoand
heterooligom
biolog
activ
speci
principl
small
nake
infecti
dna
rna
strand
thousand
base
somehow
enter
live
cell
replic
translat
cellular
enzym
final
leav
cell
infect
new
one
would
suffic
qualifi
viru
oblig
parasit
need
host
energysuppli
proteinsynthes
capabl
nevertheless
virus
gener
bear
exterior
coat
capsid
envelop
varieti
enzym
auxiliari
protein
mani
avail
access
due
compartment
infect
cell
recent
increas
public
awar
research
viral
protein
benefit
increas
fund
eg
vizier
project
wwwviziereuropeorg
sepsda
project
sar
coronaviru
wwwsepsda
info
result
flood
structur
inform
becom
avail
help
propel
discoveri
antivir
lead
compound
structurebas
drug
design
virtual
screen
review
current
structur
studi
viral
enzym
summar
discuss
discuss
studi
within
framework
viral
life
cycl
compos
entri
hijack
take
control
dodg
defens
replic
transcript
translat
final
exit
stage
viral
protein
usual
divid
structur
nonstructur
type
although
enzym
classifi
nonstructur
structur
protein
may
display
enzymat
activ
well
viral
enzym
involv
entri
exit
step
discuss
one
section
membran
receptor
bind
enzymat
process
therefor
discuss
often
viral
glycoprotein
bind
cellular
receptor
one
domain
fragment
catalyz
membran
fusion
anoth
domain
latter
activ
exhibit
structur
protein
consid
enzymat
see
detail
review
structur
fusion
core
describ
past
two
year
mention
includ
relev
fragment
sar
coronaviru
cov
spike
protein
see
review
human
parainfluenza
viru
f
protein
semliki
forest
viru
glycoprotein
dengu
viru
envelop
e
protein
see
also
glycoprotein
b
herp
simplex
viru
upon
ph
shift
andor
proteolyt
cleavag
protein
undergo
conform
chang
therebi
expos
hydrophob
fusion
peptid
insert
host
cell
membran
effici
egress
newli
form
virion
host
cell
receptor
molecul
locat
surfac
infect
cell
modifi
degrad
influenza
neuraminidas
sialidas
cleav
sialic
acid
moieti
receptor
molecul
therebi
prevent
rebind
virus
surfac
alreadi
infect
host
cell
recent
xray
structur
avian
influenza
viru
neuraminidas
typei
neuraminidas
determin
reveal
extra
caviti
adjac
activ
site
close
upon
ligand
bind
pdb
code
latter
two
structur
contain
drug
oseltamivir
caviti
observ
typeii
variant
enzym
use
structurebas
design
oseltamivir
tamiflu
zanamivir
relenza
thu
find
open
new
avenu
design
neuraminidas
inhibitor
hijack
engag
host
defens
acquir
cell
control
viru
insid
host
cell
need
take
control
cell
evad
host
defens
strategi
initi
time
manner
replic
translat
process
viral
offens
measur
affect
wide
varieti
host
defens
strategi
exampl
modif
signal
pathway
cellular
machin
interferon
play
key
role
cell
defens
virus
counteract
accordingli
recognit
viral
nucleic
acid
patternrecognit
receptor
eg
tolllik
receptor
cytosol
rna
helicas
rigi
review
first
step
induct
innat
immun
system
virus
strike
back
serin
proteas
hepat
c
viru
hcv
cleav
cardif
adaptor
molecul
involv
recognit
viral
dsrna
retino
acid
induc
genei
rigi
therebi
block
interferonb
product
simian
viru
v
protein
hijack
dna
damag
bind
protein
ubiquitin
ligas
complex
insert
entir
helix
pocket
form
two
domain
threebpropel
structur
pdb
code
induc
degrad
stat
signal
transduc
activ
transcript
therebi
obstruct
interferon
signal
furthermor
interferoninduc
dsrnastimul
protein
kinas
pkr
key
player
innat
respons
viral
infect
target
mani
dna
rna
virus
review
exampl
human
cytomegaloviru
hcmv
gene
product
seem
sequest
pkr
nucleu
away
activ
cytoplasm
dsrna
substrat
eukaryot
initi
factor
consequ
phosphoryl
subsequ
shutdown
protein
synthesi
prevent
besid
crippl
evad
host
defens
virus
need
slow
host
mrna
translat
promot
viral
mrna
often
achiev
modif
eukaryot
initi
factor
eif
poli
bind
protein
pabp
like
picornaviru
caliciviru
proteas
see
proteas
effici
cleav
pabp
cystein
proteinas
coxsackieviru
see
cleav
eukaryot
initi
factor
therebi
block
host
mrna
translat
host
mrna
translat
host
defens
perturb
viral
transcript
translat
proceed
promptli
virus
ensur
capindepend
eukaryot
initi
viral
subgenom
mrna
translat
proceed
normal
employ
specif
viral
protein
andor
intern
ribosom
entri
site
ire
recruit
ribosom
instead
g
cap
structur
end
sub
genom
rna
sever
case
coval
link
viral
protein
vpg
viral
protein
genomelink
see
next
section
appear
substitut
termin
g
cap
moieti
ribosom
recruit
use
gstbase
pulldown
assay
vpg
shown
interact
sever
eif
ribosom
protein
norovirusinfect
cell
untransl
region
turnip
yellow
mosaic
viru
tymv
harbor
trnalik
structur
tl
act
molecular
trojan
hors
respons
intern
initi
polyprotein
synthesi
replic
nucleic
acid
protein
synthesi
dna
rna
virus
alik
encod
least
one
protein
involv
nucleic
acid
synthesi
wherea
rna
virus
rnadepend
polymeras
dna
viru
genom
mere
encod
helicas
eg
parvovirus
polyomavirus
primas
eg
herp
simplex
viru
yet
other
encod
complet
machineri
dna
replic
eg
poxviru
translat
contrast
depend
host
cell
ribosom
translat
factor
would
requir
major
effort
encod
larg
part
translat
machin
bacteria
differ
macromolecul
rna
protein
directli
involv
protein
biosynthesi
nearli
organ
ribosom
locat
cytosol
host
cell
translat
apparatu
freeli
access
type
virus
need
carri
translat
factor
contrast
nucleic
acid
synthesi
mani
relev
host
enzym
contain
nucleu
mimiviru
remark
except
rule
viru
carri
substanti
portion
translat
apparatu
viral
enzym
notori
difficult
handl
crystal
mani
part
larger
assembl
pure
concentr
state
singl
isol
protein
often
tend
aggreg
nevertheless
threedimension
structur
determin
viral
enzym
polymeras
helicas
especi
proteas
prove
amen
crystal
two
main
class
viral
rnadepend
rna
polymeras
rdrp
review
primer
depend
primer
independ
de
novo
picornaviru
caliciviru
rdrp
repres
one
class
display
access
activ
site
caviti
enabl
accommod
small
vpg
protein
act
primer
protein
rna
synthesi
footandmouth
diseas
viru
fmdv
vpg
protein
line
rnabind
cleft
correspond
rdrp
pdb
code
posit
oh
group
molecular
mimic
free
oh
group
nucleic
acid
primer
activ
site
nucleotidylyl
therebi
initi
replic
presenc
oligoadenyl
utp
product
reaction
vpgump
observ
crystal
structur
pdb
code
posit
remark
similar
posit
templateprim
rna
duplex
pdb
code
see
also
figur
nucleotidylyl
vpg
larger
structur
rearrang
rdrp
follow
mark
transit
initi
elong
phase
rna
synthesi
contrast
class
reoviru
flaviviru
rdrp
contain
addit
structur
element
fill
activ
site
caviti
see
therebi
enabl
de
novo
rna
synthesi
use
singl
ntp
primer
see
also
rdrp
major
target
develop
antivir
compound
thumb
domain
rdrp
hcv
bind
site
thiophenebas
nonnucleosid
inhibitor
nni
pdb
code
alloster
gtp
see
close
proxim
appar
part
thumb
domain
locat
approxim
away
polymeras
activ
site
palm
domain
fulfil
import
regulatori
function
modul
gtp
nni
bind
dimer
structur
hcv
domain
larg
phosphoprotein
activ
compon
hcv
replicas
reveal
groov
expos
residu
pdb
code
groov
larg
enough
accommod
rna
helix
ntermin
amphipath
ahelix
place
membran
essenti
assembl
function
viral
replic
complex
polyadenyl
polymeras
heterodim
vaccinia
viru
made
catalyt
compon
polyadenyl
polymeras
capspecif
mrna
methyltransferas
process
factor
pdb
code
polyadenyl
mrna
poxvirus
crucial
virion
matur
recent
structur
dna
polymeras
hcmv
herp
simplex
viru
report
sinc
global
outbreak
sar
much
effort
invest
elucid
structur
compon
sarscov
replicas
complex
howev
structur
rdrp
also
call
nonstructur
protein
remain
elus
far
due
difficulti
produc
fulllength
protein
suffici
quantiti
crystal
crystal
structur
hexadecamer
complex
determin
recent
pdb
code
complex
featur
central
channel
diamet
figur
suffici
wide
accommod
dsrna
togeth
posit
electrostat
potenti
inner
wall
channel
suggest
may
function
process
factor
rdrp
reminisc
b
clamp
bacteri
dna
polymeras
nice
exampl
success
function
assign
nsp
unknown
function
result
structur
proteom
project
deal
sarscov
previous
function
ssrnabind
protein
correctli
deduc
crystal
structur
viral
protein
shown
contain
disulfid
bond
even
though
fold
reduc
environ
eukaryot
host
cytoplasm
enzym
involv
disulfid
bond
isomer
perhap
other
catalyz
peptidylprolyl
cistran
isomer
may
therefor
play
role
viral
infect
underscor
structur
function
investig
vaccinia
viru
disulfid
oxidoreductas
enzym
display
thioredoxin
fold
usual
cysxxci
motif
viral
proteas
essenti
process
viral
encod
polyprotein
replic
coand
posttransl
step
import
viral
replic
assembl
infect
potenti
target
antivir
drug
seem
proteas
least
rna
virus
could
qualifi
target
inhibitor
desir
rel
broad
specif
due
similar
overal
architectur
substratebind
site
crystal
structur
birnaviru
proteas
blotch
snakehead
viru
visual
first
time
serinelysin
catalyt
dyad
viral
world
pdb
code
amino
group
lysin
residu
almost
complet
buri
therefor
probabl
deproton
bacteri
proteas
use
similar
activ
site
includ
lexa
lon
proteas
although
latter
enzym
oligomer
requir
atp
hydrolysi
proteolyt
activ
name
domain
picornaviru
polyprotein
larg
number
proteas
rna
virus
chymotrypsinlik
fold
protein
cystein
rather
serin
residu
nucleophil
two
crystal
structur
close
relat
noroviru
proteas
reveal
activ
site
featur
catalyt
cyshisglu
triad
pdb
code
cystein
replac
serin
suggest
enzym
work
gener
base
mechan
involv
noncharg
cyshi
pair
rather
thiolateimidazolium
ion
pair
shown
exist
papainlik
proteinas
picornaviru
genom
compris
singlestrand
messengerori
rna
molecul
kb
use
templat
replic
translat
process
singl
polyprotein
encod
genom
initi
proteinas
pro
cleav
bond
structur
protein
n
terminu
subsequ
complet
proteinas
pro
precursor
addit
polyprotein
process
pro
coxsackieviru
involv
cleav
dystrophin
lead
acquir
dilat
cardiomyopathia
interrupt
host
protein
synthesi
cleav
eukaryot
initi
factor
well
pabp
nmr
structur
publish
pro
coxsackieviru
reveal
expect
chymotrypsinlik
architectur
proper
cyshisasp
catalyt
triad
pdb
code
triad
also
seen
proteinas
fmdv
pdb
code
tobacco
etch
viru
pdb
code
signific
earlier
structur
picornaviru
proteinas
reveal
irregular
regard
acid
partner
catalyt
triad
either
aspart
residu
found
orient
away
activ
site
histidin
hepat
viru
pro
pdb
code
replac
glutam
polioviru
pro
human
rhinoviru
pro
pdb
code
recent
determin
structur
proteinas
coxsackieviru
k
anand
et
al
unpublish
viral
proteas
mention
thu
far
less
prefer
glutamin
glutam
residu
posit
substrat
although
distinct
clear
case
enzym
fmdv
howev
chymotrypsinlik
serin
proteas
sesbania
mosaic
viru
semv
ssrna
plant
sobemoviru
specif
glutam
activ
enzym
modul
bind
vpg
whose
residu
believ
interact
expos
aromat
patch
near
c
terminu
semv
proteinas
pdb
code
thu
least
three
differ
function
describ
vpglike
peptid
viral
replic
substitut
termin
g
cap
moieti
bind
initi
factor
ribosom
recruit
act
primer
viral
rna
synthesi
increas
activ
certain
viral
proteas
anoth
chymotrypsinlik
viral
proteas
whose
catalyt
activ
augment
peptid
cofactor
proteas
hcv
pdb
code
enzym
continu
target
numer
effort
drug
design
eg
addit
chymotrypsinlik
bbarrel
domain
ii
coronaviru
main
proteinas
pro
also
call
proteinas
pro
ctermin
helic
domain
involv
dimer
enzym
catalyt
center
consist
cyshi
dyad
posit
third
member
proper
triad
taken
highli
conserv
water
molecul
involv
multipl
hydrogenbond
interact
anoth
uniqu
featur
present
proteas
n
terminu
one
pro
monom
involv
shape
substratebind
site
therefor
dimer
essenti
catalyt
activ
among
proteas
famili
sarscov
pro
far
best
investig
paramount
import
target
treatment
sar
phdepend
switch
propos
respons
activ
enzym
low
ph
least
one
monom
homodimer
enzym
tend
catalyt
incompet
conform
oxyanion
hole
pocket
collaps
wherea
monom
appear
activ
higher
ph
transit
two
conform
believ
depend
protonationdeproton
histidin
residu
interact
glutamin
residu
substrat
reproduc
use
molecular
dynam
simul
sever
structur
complex
peptidomimet
inhibitor
determin
enzym
compound
acyl
activ
site
cystein
residu
also
describ
potent
inhibitor
peptidyl
aldehyd
design
synthes
potenti
revers
inhibitor
silico
screen
effort
result
identif
noncoval
binder
act
competit
inhibitor
pro
perform
cleavag
reaction
necessari
process
coronavir
polyprotein
gener
compon
replicas
machineri
remain
three
cleavag
site
nproxim
portion
polyprotein
substrat
viral
papainlik
proteinas
pl
pro
coronavirus
two
enzym
pro
pro
sar
viru
genom
encod
latter
interestingli
found
proteas
cleav
polyprotein
lxgg
sequenc
also
deubiquitin
function
crystal
structur
sarscov
pl
pro
pdb
code
reveal
enzym
compris
four
distinct
domain
figur
three
form
extend
righthand
architectur
nicknam
thumb
palm
finger
although
differ
correspond
featur
dna
polymeras
ntermin
residu
form
distinct
ubiquitinlik
domain
activ
site
compris
catalyt
cyshisasp
triad
cystein
contribut
thumb
domain
two
residu
palm
domain
tip
finger
domain
carri
structur
zinc
ion
ligat
four
cystein
sidechain
closest
structur
rel
sarscov
pl
pro
cellular
deubiquitin
enzym
hausp
herpesassoci
ubiquitinspecif
proteas
ubiquitinspecif
proteas
addit
ubiquitin
sarscov
pl
pro
also
remov
target
protein
ubiquitinlik
molecul
induc
interferon
ab
part
innat
immun
respons
viral
infect
appar
sarscov
protect
interferontrigg
structur
sarscov
pl
pro
deubiquitinas
pdb
code
ntermin
region
form
distinct
ubiquitinlik
domain
righthand
side
three
domain
form
extend
righthand
architectur
thumb
palm
finger
region
activ
site
compris
catalyt
cyshisasp
triad
label
cystein
contribut
thumb
domain
two
residu
palm
domain
tip
finger
domain
lefthand
side
structur
zinc
ion
ligat
four
cystein
sidechain
innat
immun
respons
interf
ubiquitin
conjug
pathway
role
ntermin
ubiquitinlik
domain
carri
pl
pro
ratia
et
al
entertain
interest
idea
may
serv
decoy
detract
cellular
ubiquitin
enzym
modifi
protein
sarscov
final
sever
virus
encod
glycosyltransferas
involv
posttransl
modif
structur
protein
paramecium
bursaria
chlorella
viru
pcbv
probabl
first
viru
known
encod
enzym
involv
sugar
metabol
ntermin
domain
pbcv
gdpdmannos
dehydratas
adopt
modifi
rossmann
fold
display
sevenstrand
parallel
bsheet
topolog
smaller
ctermin
domain
probabl
involv
nucleotidesugar
substrat
bind
sulfolobu
turret
icosahedr
viru
stiv
glycosyltransferas
possess
glycosyltransferas
superfamili
fold
gta
display
canon
dxd
motif
put
catalyt
base
structur
virolog
made
signific
progress
past
year
outbreak
sar
trigger
increas
research
activ
field
includ
structur
proteom
project
viral
enzym
promis
target
antivir
drug
discoveri
drug
great
need
view
dramat
increas
number
viral
outbreak
recent
year
realiz
case
outbreak
take
least
six
month
probabl
twelv
vaccin
readi
use
henc
resort
drug
discov
preclin
develop
outbreak
cours
drug
exhibit
broad
antivir
activ
even
though
real
broadband
antivir
may
remain
illus
oppos
exist
broadband
antibacteri
preliminari
result
inhibitor
rna
viru
proteas
suggest
may
least
group
virus
suscept
one
drug
structur
result
viral
target
enzym
cours
essenti
design
inhibitor
discov
silico
screen
inde
satisfi
threedimension
structur
viral
enzym
determin
increas
pace
nice
side
effect
structur
biolog
viral
protein
especi
complex
thereof
lot
also
learnt
cellular
machin
pathway
target
virus
eg
see
also
increasingli
realiz
molecular
mimicri
seem
use
viral
compon
exampl
small
vpg
protein
abl
reprogram
redirect
larg
molecular
machin
larg
divers
dynam
viral
genom
seem
reflect
threedimension
structur
viral
protein
complex
recent
imbert
et
al
shown
complex
may
fact
constitut
second
rdrp
sarscov
quaternari
structur
complex
simian
viru
v
protein
dna
damag
bind
protein
ubiquitin
ligas
complex
reveal
singl
viral
protein
reprogram
cellular
pathway
induc
degrad
stat
therebi
obstruct
interferon
signal
achiev
insert
singl
helix
v
protein
pocket
form
two
domain
threebpropel
structur
ferrerorta
c
aria
agudo
r
perezluqu
r
escarmi
c
domingo
e
verdagu
n
structur
protein
primerpolymeras
complex
initi
genom
replic
embo
j
first
report
structur
protein
primerpolymeras
complex
involv
initi
viral
genom
replic
protein
primer
vpg
line
rnabind
cleft
rdrp
posit
oh
group
molecular
mimic
free
oh
group
nucleic
acid
primer
activ
site
nucleotidylyl
moreov
vpgump
product
nucleotidylyl
reaction
observ
within
crystal
structur
zhai
sun
f
li
x
pang
h
xu
x
bartlam
rao
z
insight
sarscov
transcript
replic
structur
hexadecam
nat
struct
mol
biol
fine
paper
provid
insight
complex
coronaviru
replicas
machineri
crystal
structur
hexadecamer
complex
describ
great
detail
adopt
two
differ
conform
complex
